TAGLIAZUCCHI, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 1.432
NA - Nord America 757
AS - Asia 440
AF - Africa 10
SA - Sud America 8
OC - Oceania 3
Totale 2.650
Nazione #
US - Stati Uniti d'America 740
IT - Italia 729
DE - Germania 220
SE - Svezia 164
CN - Cina 124
HK - Hong Kong 93
SG - Singapore 82
FI - Finlandia 50
GB - Regno Unito 42
FR - Francia 38
ID - Indonesia 36
IE - Irlanda 30
LT - Lituania 27
BE - Belgio 25
CH - Svizzera 25
ES - Italia 25
JP - Giappone 25
IN - India 23
CA - Canada 17
KR - Corea 12
CZ - Repubblica Ceca 9
MY - Malesia 9
NL - Olanda 9
TW - Taiwan 9
BG - Bulgaria 7
TR - Turchia 7
CL - Cile 5
DK - Danimarca 5
GR - Grecia 5
PH - Filippine 5
UA - Ucraina 5
ZA - Sudafrica 5
PL - Polonia 4
VN - Vietnam 4
MD - Moldavia 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
BR - Brasile 2
IQ - Iraq 2
IR - Iran 2
MO - Macao, regione amministrativa speciale della Cina 2
PK - Pakistan 2
PT - Portogallo 2
AT - Austria 1
BD - Bangladesh 1
CO - Colombia 1
EG - Egitto 1
GH - Ghana 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 2.650
Città #
Modena 150
Frankfurt am Main 149
Chandler 134
Nyköping 113
Hong Kong 84
New York 67
Ashburn 61
Singapore 48
Bologna 47
Helsinki 42
Boardman 41
Fairfield 36
Jakarta 36
Parma 33
Shanghai 28
Dublin 24
Reggio Emilia 23
Milan 21
Houston 19
Padova 19
Seattle 19
Princeton 18
San Diego 17
Turin 17
Beijing 16
Formigine 16
Leuven 15
Piacenza 15
Sassuolo 14
Decatur 13
Munich 13
Wilmington 13
Hangzhou 12
Perugia 12
London 11
Zurich 11
Barcelona 10
Cambridge 10
Woodbridge 10
Brussels 9
Osnabrück 9
Ottawa 9
San Giovanni Suergiu 9
Brno 8
Lappeenranta 8
Rome 8
Washington 8
Ann Arbor 7
Argenta 7
Bomporto 7
Paris 7
Sofia 7
Vicenza 7
East Wenatchee 6
Rossdorf 6
Bremen 5
Brescello 5
Cebu City 5
Laval 5
Madrid 5
Marseille 5
Taichung 5
Valby 5
Verona 5
Albino 4
Amsterdam 4
Assago 4
Berlin 4
Boston 4
Castelfranco Emilia 4
Chennai 4
Finale Emilia 4
Ho Chi Minh City 4
Hyderabad 4
Ispra 4
Lausanne 4
Montecarlo 4
Reims 4
Riverside 4
Saint-Fons 4
Santiago 4
UEmraniye 4
Vauderens 4
Villeneuve-d'Ascq 4
Arceto 3
Aversa 3
Bassano del Grappa 3
Brescia 3
Capannori 3
Carpi 3
Cellatica 3
Chongqing 3
Coimbatore 3
Cornellà de Llobregat 3
Courbevoie 3
Dundee 3
Eastern 3
Ferrara 3
Groningen 3
Hammersmith 3
Totale 1.732
Nome #
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 154
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 143
Repurposing the trypanosomatidic gsk kinetobox for the inhibition of parasitic pteridine and dihydrofolate reductases 105
Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase 96
Structural bases for the synergistic inhibition of human thymidylate synthase and ovarian cancer cell growth by drug combinations 90
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 85
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 84
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 82
Current Treatments to Control African Trypanosomiasis and One Health Perspective 82
Coupling a microwave-assisted process with HPLC-ELSD for the extraction, purification and analysis of bioactive policosanols from beeswax 81
Characterization and Valorization of the Agricultural Waste Obtained from Lavandula Steam Distillation for Its Reuse in the Food and Pharmaceutical Fields 80
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 79
Advances in the set-up of a fluorescence- anisotropy assay for the search of novel inhibitors of the tead-4 complexes 72
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 71
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 71
Leveraging proteomic, bioinformatic and ecotoxicology models to select new targets overcoming L. Infantum drug resistent 68
A dual-Omics approach to identify the modulated proteins/genes in THP-1 cells infected with different drug resistant L. infantum clinical isolates. 67
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 66
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 62
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 61
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 60
Proteomic contribution to the omic path for the identification of novel drugs overcoming resistance in Leishmaniasis. 58
LC-MS/MS Helps Characterizing THP-1 Cells Proteome After Infection with Drug Resistant Leishmania Strains 57
Cellular uptake and metabolic degradation of a conjugate of folic acid with an anticancer peptide targeting the human Thymidylate synthase enzyme 55
Discovery of guanidino-containing benzimidazoles as novel antifolates for Trypanosomiasis 55
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 51
Development of guanidino-containing benzimidazoles as novel folate enzymes inhibitors for the treatment of Human African Trypanosomiasis 51
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 50
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 49
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 48
Development of a sensitive biochemical tool to assess the expression levels of recombinant ectopic proteins in in vitro engineered cellular systems 42
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 41
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 40
Expression, purification, and characterization of Transcriptional Enhancer Associated Domain (hTEAD4), a promising target for anticancer agents 38
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 35
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 33
Precision medicine through proteomics studies in drug resistant colorectal cancer 32
Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 32
Integrating MS proteomics in the Medicinal Chemistry pipeline as powerful tool to overcome drug resistance issues in colorectal cancer 31
Structural insight into YAP-TEAD4 protein-protein interactions as target for cancer treatment 30
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 30
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 22
Exploring thymidylate synthase mRNA binding site 1 and human TS protein interaction with optical tweezers and bicistronic expression assay 15
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 12
Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-Trypanosoma brucei Agents 12
Leveraging proteomics, bioinformatics, and ecotoxicology models to select new targets overcoming L infantum drug resistance. 11
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 10
Preclinical investigation of H80 compared to miltefosine: imaging and proteomics for sustainable drug development 4
Advancing sustainable drug development: comparative preclinical study of H80 and Miltefosine using imaging and proteomics 3
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 1
Totale 2.707
Categoria #
all - tutte 15.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 3 10 11 30
2021/2022369 26 12 2 2 2 47 18 32 50 41 85 52
2022/2023859 87 69 30 61 76 71 85 99 122 32 73 54
2023/20241.302 62 78 87 73 321 86 84 104 37 40 181 149
2024/2025123 112 11 0 0 0 0 0 0 0 0 0 0
Totale 2.707